-+ 0.00%
-+ 0.00%
-+ 0.00%

Quantum Biopharma Three-Month Net Loss Narrows 90% Year Over Year to USD 474,279 for Period Ended September 30, 2026

PUBT·11/12/2026 21:36:00
Listen to the news
Quantum Biopharma Three-Month Net Loss Narrows 90% Year Over Year to USD 474,279 for Period Ended September 30, 2026
  • Quantum Biopharma’s net loss narrowed 90% year-over-year to USD 474,279 for the three months ended September 30, 2026.
  • Total operating expenses fell 24% year-over-year to USD 3.56 million.
  • Cash used in operating activities declined 21% year-over-year to USD 6.25 million for the nine months ended September 30, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quantum Biopharma Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001185185-26-005323), on November 12, 2026, and is solely responsible for the information contained therein.